AzTrials
AzTrials

Alcohol Use, UnspecifiedNCT03096860

Effect of Concurrent Hookah and Alcohol Consumption on Smoking Topography and Toxicant Exposure

A study testing Active alcohol consumption in people with Alcohol Use, Unspecified and Hookah Smoking, run by Oklahoma State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the current study is to investigate in a prospective randomized cross-over trial, the impact of alcohol versus a placebo drink on smoking behavior and topography (duration and frequency of puffing), abuse liability, and toxicity. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Alcohol Use, Unspecified, Hookah Smoking
What is being tested?
Active alcohol consumption
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
1 siteUnited States
Study dates
22 Feb 2017to 10 Oct 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Report using hookah at least 1 time per month over the past 6 months
  • Are at least 21 years old
  • Speak and understand English
  • Do not currently suffer from lung disease including asthma, CF, or COPD
  • Do not currently suffer from heart disease
  • Are not currently pregnant or breast-feeding or have plans to become pregnant or begin breast-feeding at any point during the study
Show all 17Show fewer
  • No current, regular use of >5 cigarettes or other tobacco products (e.g., e-cig, cigar, etc.) per month.
  • No current marijuana use > 5 times per month
  • No use of illicit drugs during the past 30 days
  • willing to provide informed consent and abstain from all tobacco, nicotine, and marijuana use for at least 12 hours and abstain from alcohol for at least 24 hours prior to each of the two sessions
  • Live within 25 miles of the study location.
  • Have a friend who is eligible and willing to participate.
  • Consume 2 or more or one or more drinks per episode for men and women, respectively
  • Drink alcohol at least one time per week
  • Not currently be seeking treatment for alcohol use
  • Able to answer at least two hookah-specific screening questions from the screener.
  • -

Who cannot join

  • Hookah use less than one time per month over the past 6 months
  • Under the age of 21
  • Unwilling to abstain from alcohol for 24 hours and tobacco and nicotine products 12 hours prior to each study visit
  • Live more than 25 miles from the study location
  • Pregnant or breast feeding or plan to become pregnant or begin breast feeding at any point in the study -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Oklahoma Tobacco Research Center

    Oklahoma City, Oklahoma, 73104

Other trials in United States

About this study

The purpose of the current study is to investigate in a prospective randomized cross-over trial, the impact of alcohol versus a placebo drink on smoking behavior and topography (duration and frequency of puffing), abuse liability, and toxicity. It is hypothesized that drinking alcohol before smoking will be associated with longer puffs and shorter duration between puffs and greater abuse liability and toxicity.

Being tested
Active alcohol consumption, Placebo consumption
Medical subject headings
Alcohol Drinking, Water Pipe Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active alcohol consumptionOther

    Comparison of alcohol consumption vs. placebo consumption and hookah smoking.

  • Placebo consumptionOther

    Comparison of alcohol consumption vs. placebo consumption and hookah smoking.

Study groups in NCT03096860
Study groupRoleWhat they receive
Alcohol consumption and hookahExperimentalNot described
Receives: Other: Active alcohol consumption
Placebo consumption and hookahPlacebo comparatorNot described
Receives: Other: Placebo consumption

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total volume smoke inhaled

    hookah topography

    Measured: up to 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2017
  2. Study start22 Feb 2017
  3. Primary completion10 Oct 2017
  4. Study completion10 Oct 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03096860
Sponsor's protocol ID
NIH/NIDA F31 DA04252
Status last verified
Oct 2017
First submitted
20 Mar 2017
Last updated
13 Oct 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Leavens ELS, Morgan TL, Brett EI, Patzkowsky K, Son J, Molina N, Eissenberg T, Shihadeh A, Leffingwell TR, Wagener TL. Concurrent Alcohol Use and Waterpipe Tobacco Smoking: Smoking Topography, Toxicant Exposure, and Abuse Liability. Nicotine Tob Res. 2020 Feb 6;22(2):280-287. doi: 10.1093/ntr/ntz032.

    PubMed 30820567

Questions about this trial

What is this clinical trial studying?

A study testing Active alcohol consumption in people with Alcohol Use, Unspecified and Hookah Smoking, run by Oklahoma State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 17 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total volume smoke inhaled (time frame: up to 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03096860, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in